Royal Bank Of Canada Corcept Therapeutics Inc Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Royal Bank Of Canada holds 15,980 shares of CORT stock, worth $798,520. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,980

Previous 161,416 90.1%

Holding current value

$798,520

Previous $5.24 Million 85.91%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$29.51 - $46.26 $4.29 Million - $6.73 Million	-145,436 Reduced 90.1%	15,980 $739,000
Q2 2024 Aug 14, 2024	SELL	$22.21 - $34.48 $578,503 - $898,100	-26,047 Reduced 13.89%	161,416 $5.24 Million
Q1 2024 Nov 05, 2024	BUY	$21.1 - $27.46 $549,591 - $715,250	26,047 Added 16.14%	187,463 $4.72 Million
Q1 2024 May 15, 2024	BUY	$21.1 - $27.46 $3.41 Million - $4.43 Million	161,444 Added 620.49%	187,463 $4.72 Million
Q4 2023 Feb 14, 2024	BUY	$24.82 - $32.88 $279,795 - $370,656	11,273 Added 76.45%	26,019 $845,000
Q3 2023 Nov 14, 2023	BUY	$21.97 - $33.8 $159,040 - $244,678	7,239 Added 96.43%	14,746 $401,000
Q2 2023 Aug 14, 2023	SELL	$21.44 - $25.15 $386,177 - $453,001	-18,012 Reduced 70.58%	7,507 $167,000
Q1 2023 May 15, 2023	BUY	$19.2 - $24.47 $65,568 - $83,565	3,415 Added 15.45%	25,519 $552,000
Q4 2022 Feb 14, 2023	BUY	$19.95 - $29.96 $298,013 - $447,542	14,938 Added 208.46%	22,104 $448,000
Q3 2022 Nov 14, 2022	SELL	$24.7 - $29.12 $176,555 - $208,149	-7,148 Reduced 49.94%	7,166 $184,000
Q2 2022 Aug 15, 2022	BUY	$17.33 - $25.3 $127,774 - $186,536	7,373 Added 106.22%	14,314 $340,000
Q1 2022 May 16, 2022	SELL	$16.53 - $25.21 $197,368 - $301,007	-11,940 Reduced 63.24%	6,941 $156,000
Q4 2021 Feb 14, 2022	SELL	$17.1 - $23.34 $815,755 - $1.11 Million	-47,705 Reduced 71.64%	18,881 $373,000
Q3 2021 Nov 15, 2021	SELL	$19.68 - $22.53 $89,642 - $102,624	-4,555 Reduced 6.4%	66,586 $1.31 Million
Q2 2021 Aug 16, 2021	BUY	$19.97 - $24.43 $1.42 Million - $1.74 Million	71,141 New	71,141 $1.57 Million

Others Institutions Holding CORT

# of Institutions

346

Shares Held

86.1M

Call Options Held

1.12M

Put Options Held

667K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.35B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Corcept Therapeutics Inc Transaction History